Published on 27 Jan 2025 on Benzinga · via AOL
Pfizer's Conditionally Approved Braftovi Combo Therapy Regime Shows Improved...
On Saturday, Pfizer Inc. (NYSE:PFE) revealed results from the Phase 3 BREAKWATER trial evaluating...
Want to become a better investor?
Start tracking your investments with Statfolio
Sign up for free